Oral News and Research

RSS

Addition of insulin sensitizer provides lipid benefits for patients with type 2 diabetes

Results of three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combination with a sulfonylurea, metformin or insulin, resulted in triglyceride decreases and high-density lipoprotein (HDL) cholesterol increases that demonstrated statistically significant improvements from baseline.

30 Apr 2004

Scientists have discovered a genetic cause of cleft lip and palate in mice

By watching mice “dance” and comparing the DNA of the dancers to their flat-footed siblings, scientists have discovered a genetic cause of cleft lip and palate in mice, a finding that is already being used to search for a similar genetic defect in humans.

29 Apr 2004

Pre-diabetes is far more common in America than previously believed

"Pre-diabetes" -- a condition that raises a person's risk of developing type 2 diabetes, heart disease, and stroke -- is far more common in America than previously believed, according to a new HHS estimate released today.

29 Apr 2004

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Two studies presented today at the American Academy of Neurology (AAN) 56th Annual Meeting show that pregabalin, when used as an add-on treatment for epilepsy, does not affect male reproductive function or interfere with the effectiveness of oral contraceptives.

29 Apr 2004

Study of an oral fumarate shows improvement in psoriasis

Biogen Idec and Fumapharm AG today announced results from a Phase II study of BG-12, an oral fumarate, in patients with severe psoriasis.

29 Apr 2004

Vocal surgery is now available to maintain performance level of the singing voice

Tissue in the vocal cords and the female reproductive system react similarly to the hormonal changes present during a woman’s menstrual cycle. In some women, the change in vocal cord tissue is pronounced, resulting in what researchers call “premenstrual voice syndrome” (PMVS).

29 Apr 2004

Researchers are pioneering regenerative medicine techniques that could help millions of Americans heal faster after dental surgeries

More than 10 million Americans undergo surgical tooth extractions every year, and the procedure invariably involves some loss of bone from the tooth socket. This bone loss is problematic for dentists because it can compromise both the functional and esthetic outcomes of treatment involving dentures and bridges. Significant losses of bone also make it difficult for surgeons to properly fit dental implants to the ridge of the jawbone without requiring additional surgical procedures.

28 Apr 2004

Helix BioMedix announces positive results of comparative product anti-wrinkle study

Helix BioMedix today announced that it has completed a 12-week consumer product test comparing the company's anti-wrinkle peptide, HB168 with Renova(R), a currently marketed FDA approved product.

27 Apr 2004

Canadian company requested to ship Dengue Fever test kits to Hong Kong immediately

Medical Services International Inc. has announced that it has been requested to ship VScan Dengue Fever test kits to Hong Kong immediately.

27 Apr 2004

FDA fast tracks human African sleeping sickness (Trypanosomiasis) drug

Immtech International, Inc. has announced that the U.S. Food and Drug Administration has granted Immtech's first oral drug, DB289, fast track drug development designation for use to treat human African sleeping sickness (Trypanosomiasis).

26 Apr 2004

Severe Acute Respiratory Syndrome (SARS) overview

Severe Acute Respiratory Syndrome (SARS) is an atypical form of pneumonia that first appeared in November 2002 in Guangdong Province, China.

24 Apr 2004

Spice turmeric corrects the cystic fibrosis defect

Scientists at The Hospital for Sick Children (Sick Kids) and Yale University School of Medicine have found that a compound in the spice turmeric corrects the cystic fibrosis defect in mice. This research is reported in the April 23, 2004 issue of the journal Science.

24 Apr 2004

CellCept linked to reduced cancer incidence

A study presented today at an international transplant meeting showed that heart transplant patients treated with the immunosuppressant CellCeptÒ (mycophenolate mofetil) in standard immunosuppressive regimens had a significantly lower risk of developing cancer compared to those receiving non-CellCept-based treatment regimens.

23 Apr 2004

SkyePharma delivery technologies for respiratory drugs to feature at two international conferences

SkyePharma PLC has announced that its proprietary delivery technologies for respiratory drugs will be presented later this month at two international conferences, one in the UK and one in America.

22 Apr 2004

Schering-Plough submits Japanese application for hepatitis C drug

Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.

22 Apr 2004

Supplements help prevent cavities in children where water quality and fluoride content is poor

Primary care clinicians who practice in areas where the water supply is deficient in fluoride should prescribe oral fluoride supplements to preschool children over the age of 6 months, according to a recommendation from the U.S. Preventive Services Task Force.

22 Apr 2004

Oral News and Research

Addition of insulin sensitizer provides lipid benefits for patients with type 2 diabetes

Scientists have discovered a genetic cause of cleft lip and palate in mice

Pre-diabetes is far more common in America than previously believed

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Study of an oral fumarate shows improvement in psoriasis

Vocal surgery is now available to maintain performance level of the singing voice

Researchers are pioneering regenerative medicine techniques that could help millions of Americans heal faster after dental surgeries

Helix BioMedix announces positive results of comparative product anti-wrinkle study

Canadian company requested to ship Dengue Fever test kits to Hong Kong immediately

FDA fast tracks human African sleeping sickness (Trypanosomiasis) drug

Severe Acute Respiratory Syndrome (SARS) overview

Spice turmeric corrects the cystic fibrosis defect

CellCept linked to reduced cancer incidence

SkyePharma delivery technologies for respiratory drugs to feature at two international conferences

Schering-Plough submits Japanese application for hepatitis C drug

Supplements help prevent cavities in children where water quality and fluoride content is poor

FDA approves Advair Diskus® for children with asthma

Turmeric corrects the cystic fibrosis defect

FDA approves new breakthrough Parkinson's drug

No relationship between HIV and oral polio vaccine

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News